Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Wall Street analysts opine that Bicycle Therapeutics plc (NASDAQ:BCYC)’s expansion beyond oncology will diversify its ...

Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning, and welcome to the Axsome Therapeutics Third ...

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

We intend to achieve our goals with a high-performing team committed to execute, focus and innovate to drive our continued growth and long-term transformation ... To report SUSPECTED ADVERSE REACTIONS ...

NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq ... Voyager is committed to maintaining a strong balance ...

This potential milestone, along with the anticipated additional data from the atumelnant Phase 2 study in congenital adrenal hyperplasia, suggests significant growth opportunities ... and ...

The job cuts are part of a business restructuring to reduce costs, 23andMe says. Along with layoffs, the company is ...

Maryland weighs making Georgia Avenue bus lanes permanent. Mayor Bowser seeks meeting with President-elect Trump to find ...